Pricing Log in Create free account

Ascendis Pharma A/S (ASND) vs Incyte Corporation (INCY)

Ascendis Pharma A/S and Incyte Corporation are both Biotechnology companies. Incyte Corporation is the larger, with a market value of $24.1B against $16.6B — 1.4× the size. Ascendis Pharma A/S trades at the lower P/E: 18.3× against 56.3×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 24.9%. Ascendis Pharma A/S has the higher net margin (71.2% vs 6.71%) and the lower return on invested capital (15.1% vs 21.6%). Across the 21 metrics below, Incyte Corporation leads on 12 and Ascendis Pharma A/S on 9.

Valuation

Metric ASND INCY Biotechnology median
P/E 18.30 56.33 10.26
P/S 13.47 4.00 9.18
P/B 9.78 4.26 2.05
Price to free cash flow 42.14 35.34 24.81
EV/EBITDA 49.51 27.88 0.65
EV/Sales 13.12 3.36 8.98
Earnings yield 5.47% 1.78% (34.89%)
Free cash flow yield 2.37% 2.83% (24.52%)

Profitability

Metric ASND INCY Biotechnology median
Gross margin 91.26% 92.69% 65.16%
Operating margin 24.84% 10.42% 0.00%
Net margin 71.20% 6.71% 0.00%
Free cash flow margin 31.97% 11.31% 0.00%
Return on equity 118.44% 7.84% (50.12%)
Return on assets 44.34% 5.92% (45.60%)
Return on invested capital 15.07% 21.56% 0.00%

Growth

Metric ASND INCY Biotechnology median
Revenue growth (TTM) 125.98% 24.88% 6.26%
EPS growth (last fiscal year) 39.89% 4,173.33% 29.88%
Revenue growth, 5-year CAGR 152.47% 14.03% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASND INCY Biotechnology median
Debt to equity 0.31 0.00 0.00
Current ratio 2.99 3.84 4.89
Net debt to EBITDA (2.16) (2.21) 1.01

Dividend

Metric ASND INCY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ASND INCY Biotechnology median
Market cap 16.64b 24.05b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack